825 Industrial Road
Suite 500
San Carlos, CA 94070
United States
650 597 5002
https://www.allakos.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 131
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Dr. Robert Alexander Ph.D. | CEO & Director | 1.5M | N/A | 1970 |
Dr. Adam L. Tomasi Ph.D. | President | 1.15M | N/A | 1970 |
Mr. Baird Radford III | Chief Financial Officer | 731.35k | N/A | 1970 |
Ms. Mary Cromwell Ph.D. | Chief Technical Officer | N/A | N/A | N/A |
Dr. Chin Lee M.D., M.P.H. | Chief Medical Officer | N/A | N/A | 1970 |
Mr. Alan Chang | Director of Medical Affairs & Data Analytics | N/A | N/A | N/A |
Allakos Inc., a clinical stage biotechnology company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States. The company's lead product candidate is AK006, which in a Phase I clinical trial for the treatment of chronic spontaneous urticaria (CSU) and other indications. The company was incorporated in 2012 and is headquartered in San Carlos, California.
Allakos Inc.’s ISS governance QualityScore as of 1 October 2024 is 10. The pillar scores are Audit: 6; Board: 10; Shareholder rights: 8; Compensation: 9.